当前位置: X-MOL 学术BMC Infect. Dis. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Cryptococcal meningitis and immune reconstitution inflammatory syndrome in a pediatric patient with HIV after switching to second line antiretroviral therapy: a case report.
BMC Infectious Diseases ( IF 3.7 ) Pub Date : 2020-01-21 , DOI: 10.1186/s12879-020-4797-2
Ssegujja Boniface Joseph Otto 1 , Paul E George 2 , Rebecca Mercedes 2 , Nicolette Nabukeera-Barungi 1
Affiliation  

BACKGROUND Cryptococcal meningitis (CCM) is a common and deadly disease among HIV-infected patients. Notable about CCM is its association with the immune reconstitution inflammatory syndrome (IRIS). Though it has been posited a switch from first to second-line antiretroviral therapy (ART) can induce CCM IRIS, a case presentation of CCM IRIS has not been published. CASE PRESENTATION A 10-year-old, HIV-infected girl who initially presented with severe headache and new-onset seizures, with cerebrospinal fluid that returned antigen, India Ink, and culture positive for Cryptococcus neoformans. Notably, 8 weeks prior to seizures, she had switched from first line to second-line ART (abacavir-lamivudine-efavirenz to zidovudine-lamivudine-lopinavir/ritonavir) due to virologic failure, with a viral load of 224,000 copies/milliliter. At time of seizures and 8 weeks on second-line ART, her viral load had reduced to 262 copies/milliliter. Her hospital course was prolonged, as she had ongoing headaches and developed bilateral cranial nerve VI palsies despite clearance of Cryptococcus from cerebrospinal fluid on antifungal therapy and therapeutic lumbar punctures. However, symptoms stabilized, and she was discharged with oral fluconazole. Cranial nerve palsies resolved 10 weeks post discharge and she has remained disease free. CONCLUSIONS We describe a case of CCM IRIS in a 10-year-old HIV infected child after changing to second-line ART. This case provides evidence that screening for cryptococcal antigenaemia prior to switch from first-line to second-line ART could be an important measure to prevent cryptococcal disease.

中文翻译:

小儿HIV患者转二线抗逆转录病毒疗法后的隐球菌性脑膜炎和免疫重建炎症综合症:一例病例报告。

背景技术隐球菌脑膜炎(CCM)是HIV感染患者中常见且致命的疾病。关于CCM值得注意的是它与免疫重建炎症综合症(IRIS)的关联。尽管已经确定从一线抗逆转录病毒疗法可以转换为二线抗逆转录病毒疗法(ART)可以诱发CCM IRIS,但尚未发表CCM IRIS的病例报告。病例介绍一名10岁,感染了HIV的女孩,最初表现为严重的头痛和新发性癫痫发作,其脑脊液返还抗原,印度墨水,并且对新隐球菌培养呈阳性。值得注意的是,在癫痫发作前8周,由于病毒学衰竭,她已从一线抗病毒治疗转为二线抗病毒治疗(阿巴卡韦-拉米夫定-依法韦仑改为齐多夫定-拉米夫定-洛匹那韦/利托那韦),病毒载量为224,000拷贝/毫升。在癫痫发作和二线抗病毒治疗8周时,她的病毒载量已降至262拷贝/毫升。尽管由于抗真菌治疗和腰椎穿刺术清除了脑脊液中的隐球菌,但她仍持续头痛和发展为双侧颅神经VI麻痹,因此延长了住院时间。但是,症状稳定了,口服氟康唑使她出院。出院后十周,颅神经麻痹消退,她仍然没有疾病。结论我们描述了一名10岁的HIV感染儿童在改为二线抗逆转录病毒治疗后发生的CCM IRIS病例。该病例提供的证据表明,从一线抗病毒治疗转至二线抗病毒治疗之前对隐球菌抗原血症的筛查可能是预防隐球菌疾病的重要措施。她的病毒载量已降至262拷贝/毫升。尽管由于抗真菌治疗和腰椎穿刺术清除了脑脊液中的隐球菌,但她仍持续头痛并发展为双侧颅神经VI麻痹,因此延长了住院时间。但是,症状稳定了,口服氟康唑使她出院。出院后十周,颅神经麻痹消退,她仍然没有疾病。结论我们描述了一名10岁的HIV感染儿童在改为二线抗逆转录病毒治疗后发生的CCM IRIS病例。该病例提供的证据表明,在从一线抗病毒治疗转到二线抗病毒治疗之前筛查隐球菌抗原血症可能是预防隐球菌疾病的重要措施。她的病毒载量已降至262拷贝/毫升。尽管由于抗真菌治疗和腰椎穿刺术清除了脑脊液中的隐球菌,但她仍持续头痛和发展为双侧颅神经VI麻痹,因此延长了住院时间。但是,症状稳定了,口服氟康唑使她出院。出院后十周,颅神经麻痹消退,她仍然没有疾病。结论我们描述了一名10岁的HIV感染儿童在改为二线抗逆转录病毒治疗后发生的CCM IRIS病例。该病例提供的证据表明,在从一线抗病毒治疗转到二线抗病毒治疗之前筛查隐球菌抗原血症可能是预防隐球菌疾病的重要措施。尽管她在抗真菌治疗和腰椎穿刺治疗中清除了脑脊液中的隐球菌,但仍持续头痛并发展为双侧颅神经VI麻痹。但是,症状稳定了,口服氟康唑使她出院。出院后十周,颅神经麻痹消退,她仍然没有疾病。结论我们描述了一名10岁的HIV感染儿童在改为二线抗逆转录病毒治疗后发生的CCM IRIS病例。该病例提供的证据表明,在从一线抗病毒治疗转到二线抗病毒治疗之前筛查隐球菌抗原血症可能是预防隐球菌疾病的重要措施。尽管她在抗真菌治疗和腰椎穿刺治疗中清除了脑脊液中的隐球菌,但仍持续头痛并发展为双侧颅神经VI麻痹。但是,症状稳定了,口服氟康唑使她出院。出院后十周,颅神经麻痹消退,她仍然没有疾病。结论我们描述了一名10岁的HIV感染儿童在改为二线抗逆转录病毒治疗后发生的CCM IRIS病例。该病例提供的证据表明,从一线抗病毒治疗转至二线抗病毒治疗之前对隐球菌抗原血症的筛查可能是预防隐球菌疾病的重要措施。口服氟康唑后出院。出院后十周,颅神经麻痹消退,她仍然没有疾病。结论我们描述了一名10岁的HIV感染儿童在改为二线抗逆转录病毒治疗后发生的CCM IRIS病例。该病例提供的证据表明,从一线抗病毒治疗转至二线抗病毒治疗之前对隐球菌抗原血症的筛查可能是预防隐球菌疾病的重要措施。口服氟康唑后出院。出院后十周,颅神经麻痹消退,她仍然没有疾病。结论我们描述了一名10岁的HIV感染儿童在改为二线抗逆转录病毒治疗后发生的CCM IRIS病例。该病例提供的证据表明,从一线抗病毒治疗转至二线抗病毒治疗之前对隐球菌抗原血症的筛查可能是预防隐球菌疾病的重要措施。
更新日期:2020-01-22
down
wechat
bug